Abbott (NYSE: ABT) reported Q3 EPS of $1.21, $0.01 better than the analyst estimate of $1.20. Revenue for the quarter came in at $10.6 billion versus the consensus estimate of $10.56 billion.

GUIDANCE:

Abbott sees Q4 2024 EPS of $1.31-$1.37, versus the consensus of $1.34.

For earnings history and earnings-related data on Abbott (ABT) click here.

Earnings Guidance

TD Cowen Reiterates Buy Rating on Abbott Labs (ABT)October 16, 2024 4:18 PM JPMorgan Reiterates Overweight Rating on Abbott Labs (ABT)October 16, 2024 4:12 PM Abbott Labs (ABT) PT Raised to $125 at JefferiesOctober 16, 2024 4:04 PM Abbott Labs (ABT) PT Raised to $130 at StifelOctober 16, 2024 3:21 PM Abbott Labs (ABT) PT Raised to $128 at Evercore ISIOctober 16, 2024 2:42 PM Abbott Reports Third-Quarter 2024 Results and Raises Midpoint of Full-Year EPS Guidance RangeOctober 16, 2024 7:30 AM